Comprehensive analysis of PD-L1 expression in glioblastoma multiforme-Reference-Cited by-同舟云学术

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme

Published:2017-02-02 Issue:26 Volume:8 Page:42214-42225
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Heiland Dieter Henrik¹²,Haaker Gerrit¹²,Delev Daniel¹²,Mercas Bianca¹²,Masalha Waseem¹²,Heynckes Sabrina¹²,Gäbelein Annette¹²,Pfeifer Dietmar³²,Carro Maria Stella¹²,Weyerbrock Astrid¹²,Prinz Marco⁴²⁵,Schnell Oliver¹²

Affiliation:

1. Department of Neurosurgery, Medical Center - University of Freiburg, Baden-Württemberg, Germany

2. Faculty of Medicine, University of Freiburg, Baden-Württemberg, Germany

3. Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center - University of Freiburg, Baden-Württemberg, Germany

4. Institute of Neuropathology, Medical Center - University of Freiburg, Baden-Württemberg, Germany

5. BIOSS Centre for Biological Signalling Studies, University of Freiburg, Baden-Württemberg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives;International Immunopharmacology;2024-12

2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

3. Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists;Pathology - Research and Practice;2024-02

4. Current state of immune checkpoints therapy for glioblastoma;Heliyon;2024-01

5. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?;Applied Immunohistochemistry & Molecular Morphology;2023-12-30